IL2 and neoplasm: In another study using the B16-F10 aggressive melanoma murine model, treated with anti-PD1 Ab, propranolol, and IL-2 interventions, the most statistically significant delay in tumor growth was in animals administered the anti-PD1 Ab/propranolol combination (10).